🇺🇸 FDA
Patent

US 9241998

Methods and compositions for treatment of cancer using oncolytic RSV activity

granted A61KA61K35/768A61K38/00

Quick answer

US patent 9241998 (Methods and compositions for treatment of cancer using oncolytic RSV activity) held by The Board of Regents of the University of Texas System expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
35
CPC classes
A61K, A61K35/768, A61K38/00, A61K38/177, A61K38/19